Hasil Pencarian - Hrishikesh Rangnekar
- Menampilkan 1 - 5 hasil dari 5
-
1
Experience with BioMatrix BES and other DES in all-comers setting: A retrospective overview oleh B.K. Goyal, B.C. Kalmath, Ramesh Kawar, Anil Sharma, Bhushan Khemnar, Hrishikesh Rangnekar
Diterbitkan 2013-12-01
Artikel -
2
A randomized controlled pilot study of add-on therapy of CIM-MEG19 (standardized Andrographis paniculata formulation) in mild to moderate COVID-19 oleh Karuna Shanker, Hrishikesh Rangnekar, Asmita Wele, Pravin Soni, Pranesh Gaikwad, Anirban Pal, Dnyaneshwar U. Bawankule, Debabrata Chanda
Diterbitkan 2023-02-01
Artikel -
3
Efficacy and safety of polyherbal formulation as an add-on to standard-of-care in mild-to-moderate COVID-19: A randomized, double-blind, placebo-controlled trial oleh Suresh B. Patankar, Anupama Gorde, Kalpana Joshi, Kishor Suryawanshi, Pravin Soni, Tejas Shah, Sagar Patankar, Diwakar Jha, Rajesh Raje, Hrishikesh Rangnekar
Diterbitkan 2022-10-01
Artikel -
4
Clinical outcomes with Biolimus (A9)™ eluting stent, ‘BioMatrix’ in diabetic patients – interim results from multicenter post market surveillance registry in India oleh Ashok Seth, Shirish Hiremath, Sameer Dani, Sunil Kapoor, R.K. Jain, Rajpal Abhaichand, Shailendra Trivedi, Upendra Kaul, Aruna Patil, Bhushan Khemnar, Hrishikesh Rangnekar
Diterbitkan 2013-09-01
Artikel -
5
One-year clinical outcomes of BioMatrix™-Biolimus A9™ eluting stent: The e-BioMatrix multicenter post marketing surveillance registry in India oleh Ashwin B. Mehta, Praveen Chandra, Jamshed Dalal, Prabhakar Shetty, Devang Desai, K. Chocklingam, Jayesh Prajapati, Pramod Kumar, Vilas Magarkar, Apurva Vasawada, B.K. Goyal, Viveka Kumar, V. Suryaprakash Rao, Ramesh Babu, Pritesh Parikh, Upendra Kaul, Aruna Patil, Tushar Mhetre, Hrishikesh Rangnekar
Diterbitkan 2013-09-01
Artikel